Newron Pharmaceuticals S.p.A. (SWX:NWRN)
Switzerland · Delayed Price · Currency is CHF 19.26
-0.12 (-0.62%)
Feb 20, 2026, 5:31 PM CET
Newron Pharmaceuticals Market Cap
Newron Pharmaceuticals has a market cap or net worth of 387.88 million as of February 20, 2026. Its market cap has increased by 107.85% in one year.
Market Cap
387.88M
Enterprise Value
396.63M
Revenue
55.93M
Ranking
n/a
PE Ratio
17.43
Stock Price
19.26
Market Cap Chart
Since December 12, 2006, Newron Pharmaceuticals's market cap has increased from 309.05M to 387.88M, an increase of 25.51%. That is a compound annual growth rate of 1.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 387.88M | -18.52% |
| Dec 30, 2025 | 476.07M | 173.36% |
| Dec 30, 2024 | 174.16M | 97.16% |
| Dec 29, 2023 | 88.33M | 219.35% |
| Dec 30, 2022 | 27.66M | -4.32% |
| Dec 30, 2021 | 28.91M | -24.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 972.07M |
| Basilea Pharmaceutica AG | 668.66M |
| Santhera Pharmaceuticals Holding AG | 227.56M |
| BioVersys AG | 138.01M |
| Molecular Partners AG | 135.38M |
| Xlife Sciences AG | 123.43M |
| EvoNext Holdings | 6.69M |
| Addex Therapeutics | 5.67M |